Docetaxel Injection, Solution
Product Images NDC 47335-939

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Docetaxel (NDC 47335-939). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-docetaxel-160mg-carton (Spl Docetaxel 160mg Carton)

Spl-docetaxel-160mg-carton (Spl Docetaxel 160mg Carton)
This is a description of Docetaxel Injection, USP which is used for intravenous infusion only. It contains 20 mg/mL of docetvel anhydrous, USP and 4 mg of citric acd anhydrous in SUSD and is a cybtoric agent. Dosage and Adminstraon information as well as instructions for use and storage are provided. The NDC number is 47335-939-40 and it is distributed by Sun Pharmaceuticals Industries, Inc.*
FDA Label Image

Spl-docetaxel-160mg-label (Spl Docetaxel 160mg Label)

Spl-docetaxel-160mg-label (Spl Docetaxel 160mg Label)
This is a description of a medication called Docetaxel Injection, USP. It comes in single-dose vials containing 160mg/8ml of the drug, which consists of 20mg of docetaxel anhydrous and 4mg of citric acid anhydrous in a 50/50 (v/v) ratio, along with polysorbate 80 and dehydrated alcohol. It is a cytotoxic agent for intravenous infusion and must be stored at 68-77°F, protected from light. Any unused portion must be discarded. It is sold with an NDC of 47335-939-40 and distributed by Sun Pharmaceutical Industries, Inc. It should be added to an infusion solution and has complete instructions in the Prescribing Information. Unfortunately, it is uncertain what Lot A Bxp: MY refers to.*
FDA Label Image

Spl-docetaxel-20mg-carton (Spl Docetaxel 20mg Carton)

Spl-docetaxel-20mg-carton (Spl Docetaxel 20mg Carton)
This is a pharmaceutical product labeled "Docetaxel Injection, USP" containing 20mg of cortans dootze sy. It is intended for intravenous infusion only. The product is ready to be added to an infusion solution and contains 1mL. The batch number is 47335-323-40 with NDC code 4733532340. The rest of the text contains warnings, precautions in regards to storage and handling, and manufacturer information.*
FDA Label Image

Spl-docetaxel-20mg-label (Spl Docetaxel 20mg Label)

Spl-docetaxel-20mg-label (Spl Docetaxel 20mg Label)
This is a description of Docetaxel Injection, USP, distributed by Sun Pharmaceutical Industries, Inc. Each mL contains 20 mg of docetaxel anhydrous and other ingredients. It is meant for intravenous infusion only and should be stored at 20°-25°C. It must be protected from light and is ready to be added to infusion solutions. The instructions should be carefully followed, and any unused portions should be discarded.*
FDA Label Image

Spl-docetaxel-80mg-carton (Spl Docetaxel 80mg Carton)

Spl-docetaxel-80mg-carton (Spl Docetaxel 80mg Carton)
This is a description for a medication called Docetaxel Injection, USP. It is a solution that is ready to be added to an infusion and is designed for intravenous use only. It contains 80 mg of medication per 4 mL solution, with a concentration of 20 mg/mL. The text includes some warnings and precautions concerning the storage and handling of the medication. There are also details on the manufacturer and product numbers.*
FDA Label Image

Spl-docetaxel-80mg-label (Spl Docetaxel 80mg Label)

Spl-docetaxel-80mg-label (Spl Docetaxel 80mg Label)
This is a description of a medication called Docetaxel Injection, USP. Each mL of the injection contains 20 mg of docetaxel anhydrous, USP and 4 mg citric acid anhydrous in a 50/50 (v/v) ratio of polysorbate 80/dehydrated alcohol. The injection is stored at 20° to 25°C (68°F to 77°F) and must be protected from light. It comes in a single-dose vial, and any unused portion must be discarded. The medication is a cytotoxic agent and is only for intravenous infusion. The injection is ready to add to the infusion solution, and the prescribing information contains complete instructions. The medication is distributed by Sun Pharmaceutical Industries, Inc. and manufactured by Sun Pharmaceutical Ind. Ltd., India. Lot information is provided as AAA### #A.*
FDA Label Image

Spl-docetaxel-chemical-structure (Spl Docetaxel Chemical Structure)

FDA Label Image

Spl-docetaxel-figure1 (Spl Docetaxel Figure1)

FDA Label Image

Spl-docetaxel-figure10 (Spl Docetaxel Figure10)

FDA Label Image

Spl-docetaxel-figure2 (Spl Docetaxel Figure2)

FDA Label Image

Spl-docetaxel-figure3 (Spl Docetaxel Figure3)

FDA Label Image

Spl-docetaxel-figure4 (Spl Docetaxel Figure4)

Spl-docetaxel-figure4 (Spl Docetaxel Figure4)
This appears to be a graph displaying the cumulative probability of survival over a period of time, measured in months. The horizontal axis shows the months of survival time, with markers at 3, 9, 12, 15, 18, and 21. The vertical axis displays the cumulative probability of survival, ranging from 0 to 1. Additionally, there is a note indicating the log-rank p value of 0.13 for overall survival.*
FDA Label Image

Spl-docetaxel-figure5 (Spl Docetaxel Figure5)

Spl-docetaxel-figure5 (Spl Docetaxel Figure5)
This text appears to be a graph or chart showing survival time in months, with values listed at every 3-month increment. Other information is not available.*
FDA Label Image

Spl-docetaxel-figure6 (Spl Docetaxel Figure6)

FDA Label Image

Spl-docetaxel-figure7 (Spl Docetaxel Figure7)

Spl-docetaxel-figure7 (Spl Docetaxel Figure7)
This appears to be a table or chart displaying survival probability percentages over a certain time period, represented in months. The first column displays percentages ranging from 0 to 100%. The second column displays a label or identifier for each percentage value, which appears to be comprised of a mix of letters and numbers. However, the specific meaning or context of this information is not clear based on the given text.*
FDA Label Image

Spl-docetaxel-figure8 (Spl Docetaxel Figure8)

FDA Label Image

Spl-docetaxel-figure9 (Spl Docetaxel Figure9)

Spl-docetaxel-figure9 (Spl Docetaxel Figure9)
This appears to be a table or graph that shows the probability of survival over time in months. The x-axis displays the survival time in months with intervals of 6 months (24, 30, 36, 42, 48). The y-axis displays the survival probability as a percentage (%). However, without further context, it is unclear what the data is referring to.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.